Metabolome profiling by untargeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of peripheral neuropathy induced by oxaliplatin.
- DOI
- 10.3389/fonc.2025.1617207
- Published
- 2025
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2025.1617207,
title = {Metabolome profiling by untargeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of peripheral neuropathy induced by oxaliplatin.},
author = {Hua YJ and Zhang Y and Wu RR and Lv J and Zhang Y and Chen YY and Ding YJ and Chen JH},
year = {2025},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2025.1617207},
url = {https://doi.org/10.3389/fonc.2025.1617207}
}RIS
TY - JOUR TI - Metabolome profiling by untargeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of peripheral neuropathy induced by oxaliplatin. AU - Hua YJ AU - Zhang Y AU - Wu RR AU - Lv J AU - Zhang Y AU - Chen YY AU - Ding YJ AU - Chen JH PY - 2025 JO - Frontiers in oncology DO - 10.3389/fonc.2025.1617207 UR - https://doi.org/10.3389/fonc.2025.1617207 ER -
APA
YJ, H., Y, Z., RR, W., J, L., Y, Z., YY, C., YJ, D., & JH, C. (2025). Metabolome profiling by untargeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of peripheral neuropathy induced by oxaliplatin.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1617207
Source records
- pubmed · retrieved 2026-09-26T20:37:16.764Z